Neuromotor Development and Motor Related Health Care in Children with a High Risk Neonatal Period
Launched by KAROLINSKA INSTITUTET · Oct 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how common motor and neurological disorders are in Swedish infants who faced serious health challenges shortly after birth, such as being born prematurely or having low oxygen levels. The study aims to understand if these children, when they reach ages 2 and 5.5 years, are receiving the necessary motor-related health care to help them develop properly.
To be part of this study, children need to be enrolled in a specific health registry and have a follow-up plan for the ages mentioned. There are no specific exclusions, so if they meet the criteria, they can participate. While the trial is not yet recruiting, families can expect that their children will be assessed for any motor or neurological issues and the care they receive will be evaluated over time. This information will help improve care for similar children in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Included in the SNQ registry and having a follow-up protocol for 2 and/or 5 years of age.
- Exclusion Criteria:
- • None if the above inclusion criteria ar true.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Maria Örtqvist, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported